↓ Skip to main content

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

Overview of attention for article published in BMC Cancer, December 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
Published in
BMC Cancer, December 2014
DOI 10.1186/1471-2407-14-991
Pubmed ID
Authors

Mourad Chaari, Ines Ayadi, Aurelie Rousseau, Eleftheria Lefkou, Patrick Van Dreden, Fatoumata Sidibe, Hela Ketatni, Vassiliki Galea, Amir Khaterchi, Racem Bouzguenda, Mounir Frikha, Lilia Ghorbal, Jamel Daoud, Choumous Kallel, Martin Quinn, Joseph Gligorov, Jean Pierre Lotz, Mohamed Hatmi, Ismail Elalamy, Grigoris T Gerotziafas

Abstract

In breast cancer patients routine thromboprophylaxis is not recommended but individualized risk assessment is encouraged. The incorporation of hypercoagulability biomarkers could increase the sensitivity of risk assessment models (RAM) to identify patients at VTE risk. To this aim we investigated the impact of cancer-related characteristics on hypercoagulability biomarkers.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 24%
Researcher 6 21%
Student > Bachelor 4 14%
Student > Postgraduate 2 7%
Professor > Associate Professor 2 7%
Other 7 24%
Unknown 1 3%
Readers by discipline Count As %
Medicine and Dentistry 10 34%
Biochemistry, Genetics and Molecular Biology 4 14%
Engineering 2 7%
Neuroscience 2 7%
Psychology 2 7%
Other 4 14%
Unknown 5 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2014.
All research outputs
#3,799,510
of 4,691,823 outputs
Outputs from BMC Cancer
#2,013
of 2,559 outputs
Outputs of similar age
#121,629
of 155,170 outputs
Outputs of similar age from BMC Cancer
#115
of 140 outputs
Altmetric has tracked 4,691,823 research outputs across all sources so far. This one is in the 3rd percentile – i.e., 3% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,559 research outputs from this source. They receive a mean Attention Score of 2.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,170 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.